Small molecules and peptides/modified peptides for diagnostic, therapeutic and biotechnological applications
CNR Ibb | back to homepage
Advanced search▼
Research areas: advanced search.
Query:
Options:       Extended  
Only from this site:
Small molecules and peptides/modified peptides for diagnostic, therapeutic and biotechnological applications
Back to Biomolecules

▼    A multi-targeting approach to fight COVID-19
▼    Analysis of Sam domain druggability through computational and experimental studies
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools
▼    Design and screening of molecular repertoires as a source for new bioactive compounds
▼    Design of New FSHR-Specific Peptides for therapeutic and diagnostic applications
▼    Development of integrin subtypes selective ligands: from a first rationally designed peptide to a wide range of molecules
▼    Drug discovery by mirror-image phage display
▼    Environmental chemistry & human health. Computational studies. Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural products in biomedicine. Nucleic acid and protein binding studies
▼    Galectins: Structure, function and therapeutic potential inhibitors
▼    New peptide–based molecules as NGF mimetics in the therapy of neurological dysfunctions
▼    New synthetic molecules for active targeting of multifunctional theranostic nanosystems
▼    Peptide-based molecules for αvβ3 integrin modulation in Th17 cells-dependent demyelinating diseases
▼    Peptides of therapeutic interest with antimicrobial and/ or antitumoral activity
▼    Plant polypeptides as natural enhancers of biostimulation
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives
▼    Targeting Of Protein-Protein Interactions For Therapeutic Purposes
▼    Targeting Sam-Sam interactions mediated by EphA2 receptor: design and evaluation of peptide inhibitors
▼    Biomolecules able to modulate the VEGF-dependent angiogenesis
Small molecules and peptides/modified peptides for diagnostic, therapeutic and biotechnological applications
Last modified by Marco Comerci on Monday 30 November 2020, 19:54:05
840 views. Last view on Friday 29 May 2026, 19:59:19